Drive access, value, and affordability with insight-led strategies, data integration, AI - enabled workflows, and analytics that power smarter contract decisions to improve economics and reduce access barriers with innovative pricing, contracting, and rebate management solutions.
IQVIA's Orchestrated Gross-to-Net platform provides unified, claim-level insights across geographies and contracts. Our platform is designed specifically for pharma financial planning, it integrates accruals, reserve insights, and variance analysis.
Discover how this analysis provides clarity for manufacturers, health systems, and policy leaders navigating an increasingly complex landscape.
Anticipate impacts of evolving state 340B policy legislation through customizable analytics by brand and geography.
Identify at-risk claims through enriched rebate and site-of-care data. Reduce revenue leakage caused by duplicate payments and incorrect pricing and analyze contract exposure trends from state-level law changes.
Address pricing challenges with advanced analytics and domain expertise.
IQVIA combines advanced analytics, proprietary healthcare data, and consulting expertise to transform insights into strategy. With claims data, formulary data, provider-level data and 3rd party data, we analyze payer behavior, patient access dynamics, and market performance to identify actionable opportunities.
Our approach goes beyond descriptive analytics to predictive insights and evidence-based decision-making to improve access and commercial outcomes.
IQVIA helps pharmaceutical and biotech companies ensure that innovative therapies achieve optimal payer coverage, reimbursement, and patient access in a complex healthcare environment. By addressing payer restrictions, pricing pressures, and patient affordability, IQVIA aligns clinical value, economic evidence, and stakeholder strategy to maximize both patient access and commercial performance. Contact us to learn more.
